Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page has updated its timeline to include newer date entries (2025-10-08, 2026-10, 2025-10-02) and a new marker “Last Update Posted (Estimated)”, and removed older timestamps (2024-10-23, 2024-10-21, and a generic “Last Update Posted” plus 2024-10). Additionally, it adds a statement about the product being manufactured in and exported from the U.S. No.
    Difference
    1%
    Check dated 2025-10-13T11:56:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Major addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.
    Difference
    5%
    Check dated 2025-10-06T07:56:57.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Core page content updated with a new version/revision and new contact details (phones and emails). Previous revision (v3.0.2) removed in favor of v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T04:17:47.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2, indicating a minor patch. The 'Back to Top' text/link was removed as a secondary UI change.
    Difference
    0.3%
    Check dated 2025-09-14T21:45:39.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-07T18:15:30.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Nivolumab and related topics, while removing several previous entries related to Relatlimab and other antineoplastic agents.
    Difference
    5%
    Check dated 2025-08-31T12:24:23.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.